Hematology NewsPretransplantation mogamulizumab for ATLL raises risk of GVHDAugust 23, 2016Leukemia, Myelodysplasia, TransplantationAggressive LymphomasT Cell LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsMetabolic tumor volume predicts outcome in follicular lymphomaAugust 22, 2016Lymphoma & Plasma Cell DisordersAggressive LymphomasFollicular Lymphoma
Oncology PracticeCancer trends shifting in HIV-positive patientsAugust 17, 2016Lung CancerLymphoma & Plasma Cell DisordersAggressive Lymphomas
Hematology NewsHIV-related lymphoma rate remains sky-high despite ARTAugust 13, 2016Aggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsBendamustine-based chemotherapy induces high CR rate in relapsed HLJuly 8, 2016Indolent LymphomaAggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsPembrolizumab shows signs of efficacy in relapsed/refractory classical Hodgkin lymphomaJuly 5, 2016Aggressive LymphomasLymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology News‘Impressive’ responses with nivolumab in relapsed Hodgkin lymphomaJune 16, 2016Aggressive LymphomasLymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology NewsDaratumumab plus len-dex stalls myeloma progression in POLLUX trialJune 15, 2016Multiple MyelomaAggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsFollicular lymphoma with histologic transformation may merit ASCTJune 14, 2016Indolent LymphomaLymphoma & Plasma Cell DisordersAggressive LymphomasFollicular Lymphoma
Hematology NewsMogamulizumab achieves objective responses in relapsed/refractory adult T-cell leukemia-lymphomaJune 10, 2016Aggressive LymphomasT Cell LymphomasLymphoma & Plasma Cell DisordersRare Diseases
Hematology NewsAlemtuzumab plus CHOP didn’t boost survival in elderly patients with peripheral T-cell lymphomasJune 10, 2016T Cell LymphomasAggressive Lymphomas
Hematology NewsFDA grants accelerated approval to nivolumab for Hodgkin lymphomaMay 17, 2016Aggressive LymphomasLymphoma & Plasma Cell DisordersRenal Cell CarcinomaHodgkin Lymphoma
Hematology NewsEpstein-Barr virus DNA in plasma reliably detects EBV-positive lymphoproliferative disordersMay 11, 2016Indolent LymphomaAggressive Lymphomas
Hematology NewsDose-escalated blinatumomab plus dexamethasone induced responses in relapsed/refractory DLBCLApril 22, 2016Aggressive LymphomasLymphoma & Plasma Cell DisordersRare Diseases
Hematology NewsFDG-PET guides need for eBEACOPP in advanced Hodgkin’sApril 12, 2016Indolent LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersHodgkin Lymphoma
